No FDA-approved medications exist, and relapse rates are alarmingly high
Clinic Secret Intro: Clinic Secret Enters the Spotlight as GLP-1 Telehealth Platforms Gain National Attention New York City, NY, Dec
No, BPC-157 is not safe for long-term use because controlled human clinical data on safety, dosage, and long-term effects remain limited
J Pineal Res 1994 Oct;17(3):132-6 [abstract] Beal MF
That means the efficacy data, such as any body weight changes cited, are based on those protocols, not on microdosing approaches
By inhibiting the dipeptidyl peptidase-4 enzyme, Linagliptin prolongs the activity of incretin hormones, thereby enhancing insulin secretion and suppressing glucagon release in a glucose-dependent manner